Infantile Epileptic Spasms Syndrome clinical trials at UCLA
1 research study open to eligible people
Showing trials for
Prevent Infantile Spasms Relapse
open to eligible people ages 2 months to 18 months
After initially successful treatment, many children with infantile spasms unfortunately have a relapse, and relapse is linked to poor long-term outcomes such as autism and other forms of epilepsy. The aim of this study is to determine if treatment with low-dose prednisolone is safe, well tolerated, and effective in reducing the risk of relapse.
Los Angeles, California
Our lead scientists for Infantile Epileptic Spasms Syndrome research studies include Shaun A. Hussain, MD, MS.
Last updated: